These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22112280)

  • 1. [Left ventricular hypertrophy and end-stage renal failure of unknown etiology: Fabry disease?].
    Arévalo-Gómez A; Rivera-García S; López-Muñiz A; Barriales-Villa R
    Rev Clin Esp; 2012 May; 212(5):265-6. PubMed ID: 22112280
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrocardiogram in Fabry's disease].
    Jastrzebski M; Petkow-Dimitrow P
    Kardiol Pol; 2008 Jun; 66(6):688-92; discussion 692-3. PubMed ID: 18626840
    [No Abstract]   [Full Text] [Related]  

  • 3. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual cause of dyspnea.
    Jamali AH; Ahmed RM; Stein H
    Cardiol Rev; 2004; 12(1):10-4. PubMed ID: 14667257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Fabry's disease: an unusual cause of left ventricular hypertrophy.
    Nunes JP; Costa O; Faria Mdo S; Almeida PB; Lacerda L
    Nat Clin Pract Cardiovasc Med; 2007 Nov; 4(11):630-3. PubMed ID: 17957210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
    Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
    N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing Fabry disease--delays and difficulties within discordant siblings.
    Brady M; Montgomery E; Brennan P; Mohindra R; Sayer JA
    QJM; 2015 Jul; 108(7):585-90. PubMed ID: 23378663
    [No Abstract]   [Full Text] [Related]  

  • 8. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report.
    Porsch DB; Nunes AC; Milani V; Rossato LB; Mattos CB; Tsao M; Netto C; Burin M; Pereira F; Matte U; Giugliani R; Barros EJ
    Ren Fail; 2008; 30(9):825-30. PubMed ID: 18925518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial disease in inherited disease].
    Nakao S
    Nihon Rinsho; 2000 Jan; 58(1):200-3. PubMed ID: 10885314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wide complex beats with ventricular hypertrophy: what is the mechanism?
    Omar AR; Harris L; Cameron DA; Chauhan VS
    J Cardiovasc Electrophysiol; 2006 Oct; 17(10):1150-2. PubMed ID: 16989653
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of patients with Fabry disease in Argentina].
    AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
    Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabry disease.
    Nagueh SF
    Heart; 2003 Aug; 89(8):819-20. PubMed ID: 12860841
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac manifestations of Fabry's disease: a story of mother and son.
    Moses H; Yarnoz MJ; Guglin M
    Congest Heart Fail; 2009; 15(2):93-5. PubMed ID: 19379456
    [No Abstract]   [Full Text] [Related]  

  • 14. [A 17-year-old male with left ventricular hypertrophy: He who does not know what he is searching for will not understand what he finds].
    Arévalo A; Rivera S; de la Cruz J; Barriales R; Montserrat L
    Rev Clin Esp; 2011 Oct; 211(9):e58-60. PubMed ID: 21536266
    [No Abstract]   [Full Text] [Related]  

  • 15. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
    Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
    J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.
    Gange CA; Link MS; Maron MS
    Circulation; 2009 Sep; 120(13):e96-7. PubMed ID: 19786638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anderson-Fabry disease and renal transplantation].
    Basić-Jukić N; Kes P; Hudolin T; Mesar I; Corić M; Kastelan Z
    Acta Med Croatica; 2011; 65(4):377-80. PubMed ID: 22359912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe left ventricular hypertrophy in Anderson-Fabry disease.
    Bhatia GS; Leahy JF; Connolly DL; Davis RC
    Heart; 2004 Oct; 90(10):1136. PubMed ID: 15367506
    [No Abstract]   [Full Text] [Related]  

  • 19. A tale of two ventricles: unusual causes of left ventricular hypertrophy.
    Pearlamn AS
    Am Heart Hosp J; 2004; 2(4):235-8. PubMed ID: 15538061
    [No Abstract]   [Full Text] [Related]  

  • 20. Deposit Diseases as Differential Diagnosis of Left Ventricular Hypertrophy in Patients with Heart Failure and Preserved Systolic Function.
    Fernandes F; Antunes MO; Hotta VT; Rochitte CE; Mady C
    Arq Bras Cardiol; 2019 Nov; 113(5):979-987. PubMed ID: 31800724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.